Cantor Fitzgerald analyst Sarah James initiated coverage of UnitedHealth with an Overweight rating and $591 price target. Heading into an election cycle in a cost-inflationary environment makes the company’s features of innovation, ROIC, and risk diversification even more valuable, the analyst tells investors in a research note. UnitedHealth will continue to be on the forefront of pushing value-based care on the payor, provider, and enablement technology fronts, which should drive its earnings growth over the next few years, the firm added.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on UNH:
- UnitedHealth management to meet virtually with Oppenheimer
- UnitedHealth price target raised to $627 from $617 at Deutsche Bank
- UnitedHealth price target lowered to $562 from $596 at TD Cowen
- UnitedHealth price target raised to $600 from $590 at Loop Capital
- Rob Arnott Says It’s Time to Buy Into Value Stocks; Here Are 2 Names That Analysts Like